These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28739691)

  • 1. Efficacy In Vitro of Caffeine and Valproic Acid on Patient-Derived Undifferentiated Pleomorphic Sarcoma and Rhabdomyosarcoma Cell Lines.
    Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Miwa S; Nelson SD; Dry SM; Li Y; Singh AS; Kimura H; Hayashi K; Yamamoto N; Tsuchiya H; Eilber FC; Hoffman RM
    Anticancer Res; 2017 Aug; 37(8):4081-4084. PubMed ID: 28739691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-toxic Efficacy of the Combination of Caffeine and Valproic Acid on Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models.
    Igarashi K; Yamamoto N; Hayashi K; Takeuchi A; Kimura H; Miwa S; Hoffman RM; Tsuchiya H
    Anticancer Res; 2016 Sep; 36(9):4477-82. PubMed ID: 27630284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetastatic Efficacy of the Combination of Caffeine and Valproic Acid on an Orthotopic Human Osteosarcoma Cell Line Model in Nude Mice.
    Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
    Anticancer Res; 2017 Mar; 37(3):1005-1011. PubMed ID: 28314258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model.
    Igarashi K; Kawaguchi K; Zhao M; Kiyuna T; Miyake K; Miyake M; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Higuchi T; Singh SR; Tsuchiya H; Hoffman RM
    Transl Oncol; 2020 Feb; 13(2):393-400. PubMed ID: 31896528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells - An Isobolographic Analysis.
    Jarząb A; Łuszczki JJ; Guz M; Gumbarewicz E; Polberg K; Stepulak A
    Anticancer Res; 2017 Mar; 37(3):1067-1074. PubMed ID: 28314266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin.
    Wittenburg LA; Bisson L; Rose BJ; Korch C; Thamm DH
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):83-92. PubMed ID: 20306194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms.
    Abaza MS; Bahman AM; Al-Attiyah RJ
    Int J Mol Med; 2014 Aug; 34(2):513-32. PubMed ID: 24899129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine and valproic acid combined treatment in vitro has enhanced cytotoxicity in an osteosarcoma cell line.
    Wang CK; Yu XD; Li Q; Xie G; Teng Y
    Asian Pac J Cancer Prev; 2013; 14(8):4651-4. PubMed ID: 24083719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
    Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
    BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.
    Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death.
    Yamanegi K; Yamane J; Kobayashi K; Kato-Kogoe N; Ohyama H; Nakasho K; Yamada N; Hata M; Fukunaga S; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Jul; 41(1):83-91. PubMed ID: 22576685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor LBH589 inhibits undifferentiated pleomorphic sarcoma growth via downregulation of FOS-like antigen 1.
    Saitoh Y; Bureta C; Sasaki H; Nagano S; Maeda S; Furukawa T; Taniguchi N; Setoguchi T
    Mol Carcinog; 2019 Feb; 58(2):234-246. PubMed ID: 30303565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression.
    Chen Z; Wu FF; Li J; Dong JB; He HY; Li XF; Lu Q; Zhang WX; Shao CM; Yao ZN; Lin N; Ye ZM; Xu JT; Li HY
    Phytomedicine; 2024 Apr; 126():155459. PubMed ID: 38417243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.
    Iwahashi S; Ishibashi H; Utsunomiya T; Morine Y; Ochir TL; Hanaoka J; Mori H; Ikemoto T; Imura S; Shimada M
    J Med Invest; 2011 Feb; 58(1-2):106-9. PubMed ID: 21372494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid enhances the anti-tumor effect of pegylated interferon-α towards pancreatic cancer cell lines.
    Sugimoto K; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Iwahashi S
    Anticancer Res; 2014 Jul; 34(7):3403-9. PubMed ID: 24982347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
    Prestegui-Martel B; Bermúdez-Lugo JA; Chávez-Blanco A; Dueñas-González A; García-Sánchez JR; Pérez-González OA; Padilla-Martínez II; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Méndez-Luna D; Trujillo-Ferrara J; Correa-Basurto J
    J Enzyme Inhib Med Chem; 2016; 31(sup3):140-149. PubMed ID: 27483122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
    Yoon JY; Ishdorj G; Graham BA; Johnston JB; Gibson SB
    Apoptosis; 2014 Jan; 19(1):191-200. PubMed ID: 24057147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
    Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
    Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.